Trials / Completed
CompletedNCT01831856
Efficacy and Safety Study of F373280
Efficacy and Safety Study of F373280 for Maintenance of Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation and Chronic Heart Failure. International, Multicentric, Randomised, Double-blind, Placebo Controlled Study.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy of F373280 on the maintenance of normal cardiac rhythm after direct electric cardioversion in patients with persistent atrial fibrillation and cardiac failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1g of F373280 | Oral administration, one capsule each evening with dinner. |
| DRUG | Placebo | Oral administration, one capsule each evening with dinner. |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2017-04-03
- Completion
- 2017-06-21
- First posted
- 2013-04-15
- Last updated
- 2019-07-02
- Results posted
- 2019-07-02
Locations
20 sites across 5 countries: Czechia, Hungary, Italy, Poland, Spain
Source: ClinicalTrials.gov record NCT01831856. Inclusion in this directory is not an endorsement.